Drugs / Ringer's Acetate
last change Aug 2022 re-read 3 minutes ago

Ringer's Acetate

Other / unclassified

Developed for
cardiac arrest · infectious disease with sepsis
Investigated by
Haukeland University Hospital · Karolinska Institutet

Trials 2

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT00347477 Sep 2005 → Apr 2007 cardiac arrest Haukeland University Hospital Completed No outcome recorded
Phase not applicable1 trial
— NCT03209271 Feb → May 2017 — Karolinska Institutet Completed No outcome recorded
Comparator or background therapy3 trials
Phase 3 NCT03277677 Comparator Jul 2017 → Jul 2018 acute kidney injury, infectious disease with sepsis Chulalongkorn University Completed No outcome recorded
Phase 3 NCT00962156 Comparator Dec 2009 → Mar 2012 infectious disease with sepsis Anders Perner Completed No outcome recorded
— NCT03553394 Comparator Oct 2018 → May 2021 pancreas disorder Uppsala University Terminated No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Ringer's Acetate “standard fluid therapy (Ringer's Acetate and saline 9 mg/ml) (control)” PMID 20500876 ↗ May 2010
4

NCT03553394 ↗

NCT03209271 ↗

NCT03277677 ↗

NCT00962156 ↗

Modality Other / unclassified “standard fluid therapy” PMID 20500876 ↗ May 2010
Route Intravenous “i.v. fluid” PMID 20500876 ↗ May 2010